Loading...
Sold out
Butycaps 60caps - Elie Health
€44,50 EUR
Unit price
/
Unavailable
Butycaps 60caps - Elie Health is backordered and will ship as soon as it is back in stock.
Description
Description
Elie Health Butycaps 60 capsules is the first dietary supplement with sterilized and microencapsulated butyric acid.
Butycaps 60 capsules from Elie Health is a dietary supplement based on microencapsulated tributyrin. Tributyrin is a triglyceride that, containing three molecules of butyric acid, ensures high bioavailability of this acid in all sectors of the intestine.
This is a form of administration that ensures high bioavailability of butyric acid in all
the sectors of the intestine.
Microencapsulation technology allows for a slower, more gradual release throughout the intestine.
Buticaps comes in the form of non-chewable granules. Each sachet contains 900mg of microencapsulated tributyrin, equivalent to 787mg of butyric acid.
Butyric acid, in turn, is a short-chain fatty acid that plays a role in nutrition, maintaining the integrity of intestinal cells, and even promoting microbiota balance. It thus plays an important metabolic and immunomodulatory role, making it essential for gastrointestinal health.
Buticaps contributes to the presence of adequate levels of butyrate in the colon, ensuring the nutrition of colonocytes, the stimulation of intestinal barrier and motility functions, increased visceral perception and decreased local inflammation.
It is especially indicated for irritable bowel syndrome, Crohn's disease, ulcerative colitis, and the prevention and treatment of colorectal carcinoma. It can also be an important ally in the treatment of inflammatory diseases, as well as in cases of insulin resistance and excess weight.
Packaging with 60 capsules .
Butycaps 60caps - Elie Health
Butycaps 60 capsules from Elie Health is a dietary supplement based on microencapsulated tributyrin. Tributyrin is a triglyceride that, containing three molecules of butyric acid, ensures high bioavailability of this acid in all sectors of the intestine.
This is a form of administration that ensures high bioavailability of butyric acid in all
the sectors of the intestine.
Microencapsulation technology allows for a slower, more gradual release throughout the intestine.
Buticaps comes in the form of non-chewable granules. Each sachet contains 900mg of microencapsulated tributyrin, equivalent to 787mg of butyric acid.
Butyric acid, in turn, is a short-chain fatty acid that plays a role in nutrition, maintaining the integrity of intestinal cells, and even promoting microbiota balance. It thus plays an important metabolic and immunomodulatory role, making it essential for gastrointestinal health.
Buticaps contributes to the presence of adequate levels of butyrate in the colon, ensuring the nutrition of colonocytes, the stimulation of intestinal barrier and motility functions, increased visceral perception and decreased local inflammation.
It is especially indicated for irritable bowel syndrome, Crohn's disease, ulcerative colitis, and the prevention and treatment of colorectal carcinoma. It can also be an important ally in the treatment of inflammatory diseases, as well as in cases of insulin resistance and excess weight.
Packaging with 60 capsules .
Specifications
Specifications
-
Warnings
